Literature DB >> 12164944

Expression of the 90K tumor-associated protein in benign and malignant melanocytic lesions.

Anna Maria Cesinaro, Clara Natoli, Antonino Grassadonia, Nicola Tinari, Stefano Iacobelli, Gian Paolo Trentini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12164944     DOI： 10.1046/j.1523-1747.2002.17642.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  6 in total

1.  Galectin-3 Binding Protein Secreted by Breast Cancer Cells Inhibits Monocyte-Derived Fibrocyte Differentiation.

Authors:  Michael J V White; David Roife; Richard H Gomer
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

2.  Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs.

Authors:  Heinz Läubli; Frederico Alisson-Silva; Michal A Stanczak; Shoib S Siddiqui; Liwen Deng; Andrea Verhagen; Nissi Varki; Ajit Varki
Journal:  J Biol Chem       Date:  2014-10-15       Impact factor: 5.157

Review 3.  Gal-3BP in Viral Infections: An Emerging Role in Severe Acute Respiratory Syndrome Coronavirus 2.

Authors:  Valentina Gallo; Alyexandra Arienzo; Stefano Iacobelli; Valentina Iacobelli; Giovanni Antonini
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

4.  Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma.

Authors:  M Nyakas; E Aamdal; K D Jacobsen; T K Guren; S Aamdal; K T Hagene; P Brunsvig; A Yndestad; B Halvorsen; K A Tasken; P Aukrust; G M Maelandsmo; T Ueland
Journal:  Clin Exp Immunol       Date:  2019-03-21       Impact factor: 4.330

Review 5.  Antibody-Drug Conjugates as an Emerging Therapy in Oncodermatology.

Authors:  Clara Esnault; David Schrama; Roland Houben; Serge Guyétant; Audrey Desgranges; Camille Martin; Patricia Berthon; Marie-Claude Viaud-Massuard; Antoine Touzé; Thibault Kervarrec; Mahtab Samimi
Journal:  Cancers (Basel)       Date:  2022-02-02       Impact factor: 6.639

6.  LGALS3BP, lectin galactoside-binding soluble 3 binding protein, promotes oncogenic cellular events impeded by antibody intervention.

Authors:  P Stampolidis; A Ullrich; S Iacobelli
Journal:  Oncogene       Date:  2013-12-23       Impact factor: 9.867
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.